Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 7, 2014, Pages R862-R868

  Richards, Jennifer P ^a   Yosten, Gina L C ^a   Kolar, Grant R ^a   Jones, Cory W ^a   Stephenson, Alan H ^a   Ellsworth, Mary L ^a   Sprague, Randy S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Adenosine Triphosphate; C peptide receptor; GPR146; Microcirculation; Red blood cell

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; OXYGEN; PHOSPHODIESTERASE III INHIBITOR;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; ERYTHROLEUKEMIA CELL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN TENSION; WESTERN BLOTTING; CELL SEPARATION; METABOLISM; PROCEDURES; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; C-PEPTIDE; CELL SEPARATION; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; HUMANS; INSULIN; MUSCLE, SKELETAL; OXYGEN;

EID: 84907627299     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00206.2014     Document Type: Article

References (50)

1. Al-Rasheed NM, Willars GB, Brunskill NJ. C-Peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soc Nephrol 17: 986–995, 2006.
2. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26: 3333–3341, 2003.
3. Ataullakhanov FI, Vitvitsky VM, Zhabotinsky AM, Pichugin AV, Platonova OV, Kholodenko BN, Ehrlich LI. The regulation of glycol-ysis in human erythrocytes. The dependence of the glycolytic flux on the ATP concentration. Eur J Biochem 115: 359–365, 1981.
4. Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy JA, Slack J. Is hyperviscosity a treatable component of diabetic microcircu-latory disease? Lancet 2: 789–791, 1977.
5. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26: 40–47, 1992.
6. Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33: 1316–1321, 1983.
7. Bo S, Gentile L, Castiglione A, Prandi V, Canil S, Ghigo E, Ciccone G. C-Peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol 167: 173–180, 2012.
8. Brown CD, Ghali HS, Zhao Z, Thomas LL, Friedman EA. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int 67: 295–300, 2005.
9. Cravarezza P, Radaeli E, Toffoli C, Rigosa C. Discrimination of type I from insulin-treated type II diabetic patients by C-peptide measurement. Acta Diabetol Lat 23: 345–350, 1986.
10. De La Tour DD, Raccah D, Jannot MF, Coste T, Rougerie C, Vague P. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 41: 1080–1084, 1998.
11. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG, Jr. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 278: H1294–H1298, 2000.
12. Djemli-Shipkolye A, Gallice P, Coste T, Jannot MF, Tsimaratos M, Raccah D, Vague P. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients. Metabolism 49: 868-872, 2000.
13. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol Heart Circ Physiol 269: H2155-H2161, 1995.
14. Ellsworth ML, Sprague RS. Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP. J Physiol 590: 4985-4991, 2012.
15. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 366: 1736-1743, 2005.
16. Forst T, De La Tour DD, Kunt T, Pfutzner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Lobig M, Engelbach M, Beyer J, Vague P. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) 98: 283-290, 2000.
17. Gambhir KK, Archer JA, Bradley CJ. Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701-708, 1978.
18. Hach T, Forst T, Kunt T, Ekberg K, Pfutzner A, Wahren J. C-Peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res 2008: 730594, 2008.
19. Hanson MS, Ellsworth ML, Achilleus D, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS. Insulin inhibits low oxygen-induced ATP release from human erythrocytes: implication for vascular control. Microcirculation 16: 424-433, 2009.
20. Heding LG, Rasmussen SM. Human C-peptide in normal and diabetic subjects. Diabetologia 11: 201-206, 1975.
21. Hills CE, Brunskill NJ. C-Peptide and its intracellular signaling. Rev Diabet Stud 6: 138-147, 2009.
22. Hills CE, Brunskill NJ. Cellular and physiological effects of C-peptide. Clin Sci (Lond) 116: 565-574, 2009.
23. Holownia P, Bishop E, Newman DJ, John WG, Price CP. Adaptation of latex-enhanced assay for percent glycohemoglobin to a Dade Dimension analyzer. Clin Chem 43: 76-84, 1997.
24. Jensen ME, Messina EJ. C-Peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol Heart Circ Physiol 276: H1223-H1228, 1999.
25. Juhan I, Vague P, Buonocore M, Moulin JP, Jouve R, Vialettes B. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1: 535-537, 1982.
26. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80: 1337-1341, 1983.
27. Kunt T, Schneider S, Pfutzner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type I diabetes mellitus. Diabetologia 42: 465-471, 1999.
28. Medawala W, McCahill P, Giebink A, Meyer J, Ku CJ, Spence DM. A molecular level understanding of zinc activation of C-peptide and its effects on cellular communication in the bloodstream. Rev Diabet Stud 6: 148-158, 2009.
29. Meyer JA, Froelich JM, Reid GE, Karunarathne WK, Spence DM. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia 51: 175-182, 2008.
30. Montalbetti N, Leal Denis MF, Pignataro OP, Kobatake E, Laz-arowski ER, Schwarzbaum PJ. Homeostasis of extracellular ATP in human erythrocytes. J Biol Chem 286: 38397-38407, 2011.
31. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
32. Nakamoto H, Sakane N, Kimura K, Yoshida T, Mochizuki S, Ogasawara Y, Kajiya F. Synergistic effects of C-peptide and insulin on coronary flow in early diabetic rats. Metabolism 53: 335-339, 2004.
33. Qiu F, Wang J, Spray DC, Scemes E, Dahl G. Two non-vesicular ATP release pathways in the mouse erythrocyte membrane. FEBS Lett 585: 3430-3435, 2011.
34. Richards JP, Stephenson AH, Ellsworth ML, Sprague RS. Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes. Am J Physiol Regul Integr Comp Physiol 305: R1331-R1336, 2013.
35. Robinson TJ, Archer JA, Gambhir KK, Hollis VW Jr, Carter L, Bradley C. Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans. Science 205: 200-202, 1979.
36. Schaper NC, Nabuurs-Franssen MH, Huijberts MS. Peripheral vascular disease and type 2 diabetes mellitus. Diabetes Metab Res Rev 16, Suppl 1: S11-S15, 2000.
37. Shin S, Ku YH, Ho JX, Kim YK, Suh JS, Singh M. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin Hemorheol Microcirc 36: 253-261, 2007.
38. Sprague RS, Bowles EA, Achilleus D, Stephenson AH, Ellis CG, Ellsworth ML. A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control. Am J Physiol Heart Circ Physiol 301: H2466-H2472, 2011.
39. Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ. Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol Heart Circ Physiol 275: H1726-H1732, 1998.
40. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol Heart Circ Physiol 271: H2717-H2722, 1996.
41. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol 281: C1158-C1164, 2001.
42. 2 supply to skeletal muscle. Am J Physiol Heart Circ Physiol 299: H566-H573, 2010.
43. Sprague RS, Hanson MS, Achilleus D, Bowles EA, Stephenson AH, Sridharan M, Adderley S, Procknow J, Ellsworth ML. Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension. Pharmacol Rep 61: 183-190, 2009.
44. Sprague RS, Stephenson AH, Bowles EA, Stumpf MS, Lonigro AJ. Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes 55: 3588-3593, 2006.
45. Sridharan M, Sprague RS, Adderley SP, Bowles EA, Ellsworth ML, Stephenson AH. Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release. Exp Biol Med (Maywood) 235: 1142-1148, 2010.
46. Steiner DF. The proinsulin C-peptide—a multirole model. Exp Diabesity Res 5: 7-14, 2004.
47. Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. C-Peptide, Na+,K(+)-ATPase, and diabetes. Exp Diabesity Res 5: 37-50, 2004.
48. van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 106: 4034–4042, 2005.
49. Williamson JR, Gardner RA, Boylan CW, Carroll GL, Chang K, Marvel JS, Gonen B, Kilo C, Tran-Son-Tay R, Sutera SP. Microrheo-logic investigation of erythrocyte deformability in diabetes mellitus. Blood 65: 283-288, 1985.
50. Yosten GL, Kolar GR, Redlinger LJ, Samson WK. Evidence for an interaction between proinsulin C-peptide and GPR146. J Endocrinol 218: B1-B8, 2013.